• Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management.
  Roggenbuck Jennifer et al. Clinics in laboratory medicine 2020 Sep 40(3) 271-287
• ALS Research Notification for Clinical Trials and Studies
  CDC/ATSDR, July 2020
• Evaluation of Vertical Ground Reaction Forces Pattern Visualization in Neurodegenerative Diseases Identification Using Deep Learning and Recurrence Plot Image Feature Extraction.
  Lin Che-Wei et al. Sensors (Basel, Switzerland) 2020 Jul 20(14)
• SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.
  Mueller Christian et al. The New England journal of medicine 2020 Jul (2) 151-158
• Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
  Miller Timothy et al. The New England journal of medicine 2020 Jul (2) 109-119
• The Beginning of Genomic Therapies for ALS.
  Hardiman Orla et al. The New England journal of medicine 2020 Jul (2) 180-181
• Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.
  Scarlino Stefania et al. International journal of molecular sciences 2020 May 21(9)
• Prevalence of C9orf72 hexanucleotide repeat expansion in Greek patients with sporadic ALS.
  Sokratous Maria et al. Amyotrophic lateral sclerosis & frontotemporal degeneration 2020 Apr 1-3
• Molecular analysis and clinical diversity of distal hereditary motor neuropathy.
  Liu Xiaoxuan et al. European journal of neurology 2020 Apr
• Prediction of caregiver burden in amyotrophic lateral sclerosis: a machine learning approach using random forests applied to a cohort study.
  Antoniadi Anna Markella et al. BMJ open 2020 Feb 10(2) e033109

more